Gemma Mudd

626 total citations
24 papers, 401 citations indexed

About

Gemma Mudd is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Gemma Mudd has authored 24 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 13 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Oncology. Recurrent topics in Gemma Mudd's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Click Chemistry and Applications (6 papers) and Chemical Synthesis and Analysis (6 papers). Gemma Mudd is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Click Chemistry and Applications (6 papers) and Chemical Synthesis and Analysis (6 papers). Gemma Mudd collaborates with scholars based in United Kingdom, Germany and Switzerland. Gemma Mudd's co-authors include Liuhong Chen, Katerine Van Rietschoten, Amy Brown, Gavin Bennett, Silvia Pavan, Philip Huxley, Nicholas Keen, Johanna Lahdenranta, Manfred Auer and Paul Beswick and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Gemma Mudd

18 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gemma Mudd United Kingdom 10 236 155 136 72 42 24 401
Lucía De Rosa Italy 14 314 1.3× 73 0.5× 70 0.5× 138 1.9× 35 0.8× 37 442
Gabriele Bassi Switzerland 12 427 1.8× 152 1.0× 149 1.1× 231 3.2× 29 0.7× 22 558
Jingli Xu United States 14 146 0.6× 113 0.7× 213 1.6× 124 1.7× 13 0.3× 33 430
Denny G.A. Johansson Sweden 5 285 1.2× 57 0.4× 43 0.3× 75 1.0× 19 0.5× 5 350
Dilraj Lama Singapore 13 386 1.6× 74 0.5× 41 0.3× 29 0.4× 11 0.3× 30 480
Eline Sijbesma Netherlands 14 700 3.0× 94 0.6× 63 0.5× 93 1.3× 12 0.3× 18 841
James Sanderson United States 10 167 0.7× 136 0.9× 389 2.9× 49 0.7× 10 0.2× 10 528
Paul Hoppenz Germany 8 236 1.0× 89 0.6× 163 1.2× 68 0.9× 27 0.6× 11 455
Lia Luus United States 10 259 1.1× 239 1.5× 247 1.8× 206 2.9× 13 0.3× 24 649
Sabrina Trüssel Switzerland 7 353 1.5× 149 1.0× 294 2.2× 184 2.6× 11 0.3× 7 578

Countries citing papers authored by Gemma Mudd

Since Specialization
Citations

This map shows the geographic impact of Gemma Mudd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gemma Mudd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gemma Mudd more than expected).

Fields of papers citing papers by Gemma Mudd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gemma Mudd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gemma Mudd. The network helps show where Gemma Mudd may publish in the future.

Co-authorship network of co-authors of Gemma Mudd

This figure shows the co-authorship network connecting the top 25 collaborators of Gemma Mudd. A scholar is included among the top collaborators of Gemma Mudd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gemma Mudd. Gemma Mudd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mix, Michael, Johanna Lahdenranta, Philip Huxley, et al.. (2025). Abstract 4601: Development and clinical translation of a phage display derived MT1-MMP-specific bicyclic peptide for radiotheranostic applications. Cancer Research. 85(8_Supplement_1). 4601–4601. 1 indexed citations
2.
Lahdenranta, Johanna, et al.. (2024). Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide. Theranostics. 14(12). 4701–4712. 9 indexed citations
3.
Walsh, Stephen J., Johanna Lahdenranta, Philip Huxley, et al.. (2024). Abstract 5807: Bicycle Toxin Conjugates®for the treatment of solid tumors. Cancer Research. 84(6_Supplement). 5807–5807.
4.
Upadhyaya, Punit, Johanna Lahdenranta, Jun Ma, et al.. (2022). Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology. Journal of Medicinal Chemistry. 65(14). 9858–9872. 11 indexed citations
5.
Rigby, Michael, Gavin Bennett, Liuhong Chen, et al.. (2022). BT8009; A Nectin-4 Targeting Bicycle Toxin Conjugate for Treatment of Solid Tumors. Molecular Cancer Therapeutics. 21(12). 1747–1756. 41 indexed citations
6.
Mudd, Gemma, Liuhong Chen, Katerine Van Rietschoten, et al.. (2022). Discovery of BT8009: A Nectin-4 Targeting Bicycle Toxin Conjugate for the Treatment of Cancer. Journal of Medicinal Chemistry. 65(21). 14337–14347. 58 indexed citations
7.
Mudd, Gemma, et al.. (2022). Gold-Mediated Multiple Cysteine Arylation for the Construction of Highly Constrained Bicycle Peptides. Bioconjugate Chemistry. 33(8). 1441–1445. 10 indexed citations
8.
Lahdenranta, Johanna, Gavin Bennett, Philip Huxley, et al.. (2021). Abstract 1319: Rapid accumulation of cytotoxic payload in tumor tissue drives BT5528 activity in tumor models. Cancer Research. 81(13_Supplement). 1319–1319.
9.
Dufort, Fay J., Gemma Mudd, Eric Haines, et al.. (2021). 789 Generation of a Bicycle NK-TICA™, a novel NK cell engaging molecule to enhance targeted tumor cytotoxicity. Regular and Young Investigator Award Abstracts. A824–A824.
10.
Bennett, Gavin, Amy Brown, Gemma Mudd, et al.. (2020). MMAE Delivery Using the Bicycle Toxin Conjugate BT5528. Molecular Cancer Therapeutics. 19(7). 1385–1394. 77 indexed citations
11.
Hurov, Kristen E., Johanna Lahdenranta, Gemma Mudd, et al.. (2020). 700 EphA2/CD137 Bicycle tumor-targeted immune cell agonists (TICAsTM) induce tumor regressions, immunogenic memory, and reprogramming of the tumor immune microenvironment. SHILAP Revista de lepidopterología. A420.2–A421. 1 indexed citations
12.
Eder, Matthias, Silvia Pavan, Ulrike Bauder‐Wüst, et al.. (2019). Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors. Cancer Research. 79(4). 841–852. 49 indexed citations
13.
Rigby, Mike, Paul Beswick, Gemma Mudd, et al.. (2019). Abstract 4479: BT8009: A bicyclic peptide toxin conjugate targeting Nectin-4 (PVRL4) displays efficacy in preclinical tumor models. Cancer Research. 79(13_Supplement). 4479–4479. 6 indexed citations
14.
Bennett, Gavin, Amy Brown, Gemma Mudd, Johanna Lahdenranta, & Nicholas Keen. (2019). Abstract 4481: BT5528, an EphA2-targeting Bicycle Toxin Conjugate (BTC): Profound efficacy without bleeding and coagulation abnormalities in animal models. Cancer Research. 79(13_Supplement). 4481–4481. 1 indexed citations
15.
Rigby, Michael, Gavin Bennett, Liuhong Chen, et al.. (2019). Abstract C061: BT8009, a Bicycle Toxin Conjugate targeting Nectin-4, shows target selectivity, and efficacy in preclinical large and small tumor models. Molecular Cancer Therapeutics. 18(12_Supplement). C061–C061. 8 indexed citations
16.
Bennett, Gavin, Philip Huxley, Amy Brown, et al.. (2018). Abstract 5855: Bicycle Drug Conjugates targeting EphA2 for the treatment of solid tumors: Discovery and selection of BT5528. Cancer Research. 78(13_Supplement). 5855–5855. 2 indexed citations
17.
Bennett, Gavin, Philip Huxley, Amy Brown, et al.. (2018). Abstract 5854: BT5528, a Bicycle Toxin Conjugate targeting EphA2 has potent anti-tumor activity without bleeding or coagulation abnormalities in preclinical models. Cancer Research. 78(13_Supplement). 5854–5854. 1 indexed citations
18.
Mudd, Gemma, et al.. (2015). A general synthetic route to isomerically pure functionalized rhodamine dyes. Methods and Applications in Fluorescence. 3(4). 45002–45002. 22 indexed citations
19.
Hintersteiner, Martin, Jörg Kallen, Mario Schmied, et al.. (2014). Identification and X‐ray Co‐crystal Structure of a Small‐Molecule Activator of LFA‐1‐ICAM‐1 Binding. Angewandte Chemie International Edition. 53(17). 4322–4326. 14 indexed citations
20.
Hintersteiner, Martin, Andrew J. S. Knox, Gemma Mudd, & Manfred Auer. (2012). Towards mimicking short linear peptide motifs: identification of new mixed α,β-peptidomimetic ligands for SLAM-Associated Protein (SAP) by confocal on-bead screening. PubMed. 5(2). 63–79. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026